Study identifier:NXL104-1004

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Official Title

-

Medical condition

-

Phase

-

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

-

Age

-

Date

Study Start Date: -
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria